Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
ISR HBV Technology AB
AB
Bankrupt
Org 5591950935
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2019 · 7 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ISR HBV Technology AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
BB
Ben Behnam Mahajerzadeh-Heidari
Audit
Audit
2024
SO
Stig Ola Winqvist
Chief Executive Officer
Chief Executive Officer
2021
Former (3)
BM
Bo Magnus Lagerberg
Chief Auditor
Chief Auditor
2021 – 2024
SL
Sven Lennart Dreyer
External Signatory
External Signatory
2021 – 2021
KÅ
Karl Åke Gunnar Modalen
External Signatory
External Signatory
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
CH
Carl Henrik Egertun
Board of Directors
Board of Directors
2024
AG
Aleksandar Gocic
Board of Directors
Board of Directors
2024
JP
Johan Peter Nylund
Board of Directors
Board of Directors
2024
JK
Jan Krister Magnelöv
Chairman
Chairman
2024
Former (3)
SJ
Stig Jonas Winqvist
Deputy Board Member
Deputy Board Member
2021 – 2024
JE
Jan Erik Gunnar Jardelöv
Board of Directors
Board of Directors
2021 – 2024
AH
Anders Harald Milton
Shareholders
As of last annual report
ISR Immune System Regulation Holding AB (publ) — 100%
100%
Shareholder
Type
Ownership
Votes
Since
ISR Immune System Regulation Holding AB (publ)
Company
100%
100%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on ISR HBV Technology AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
2021 – 2022
Chairman
Chairman
2021 – 2024